Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions
Listen to this summary
The authors aimed to assess the incidence of heart failure with improved ejection fraction (HFimpEF) across different guideline definitions and to evaluate the utilization of guideline-directed medical therapy (GDMT) and outcomes such as hospitalization or death among patients classified under each definition. They found that the prevalence of HFimpEF varied significantly based on the definition used, with a substantial proportion of patients still facing a high risk of clinical deterioration despite improvements in ejection fraction. This underscores the need for further research to optimize treatment strategies for these patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from American heart journal
View all →Sep 17, 2026 · American heart journal
Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de novo coronary lesions: a six-year analysis from the ORPKI Registry
Sep 11, 2026 · American heart journal
Accuracy of Indirect Fick Method for Systemic Flow Calculation In Adults With A Fontan Circulation
Sep 11, 2026 · American heart journal
Determinants of post-discharge LDL-C testing and target attainment after acute coronary syndrome: a 10-year population-based study
Sep 11, 2026 · American heart journal
Rural-urban differences for integrated first responder and drone automated external defibrillator delivery in North Carolina
Aug 31, 2026 · American heart journal
Clinical and Economic Outcomes in Diagnostic-Naïve Medicare Fee-for-Service Beneficiaries Managed with Alert-Based Ambulatory Cardiac Monitors: the CAMELOT-ALERT Study
Aug 30, 2026 · American heart journal
Clinical outcomes associated with recurrent compared to first-time myocardial infarction
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


